Kern Singh to Cohort Studies
This is a "connection" page, showing publications Kern Singh has written about Cohort Studies.
Connection Strength
1.791
-
Validation of VR-12 Physical Function in Minimally Invasive Lumbar Discectomy. World Neurosurg. 2021 11; 155:e362-e368.
Score: 0.137
-
The Minimum Clinically Important Difference for Patient Health Questionnaire-9 in Minimally Invasive Transforaminal Interbody Fusion. Spine (Phila Pa 1976). 2021 May 01; 46(9):603-609.
Score: 0.134
-
A Validation of Patient Health Questionnaire-9 for Cervical Spine Surgery. Spine (Phila Pa 1976). 2020 Dec 01; 45(23):1668-1675.
Score: 0.130
-
Validation of PROMIS Physical Function in MIS TLIF: 2-Year Follow-up. Spine (Phila Pa 1976). 2020 Nov 15; 45(22):E1516-E1522.
Score: 0.130
-
PROMIS PF in the Evaluation of Postoperative Outcomes in Workers' Compensation Patients Following Anterior Cervical Discectomy and Fusion. Clin Spine Surg. 2020 08; 33(7):E312-E316.
Score: 0.127
-
Diabetes Does Not Increase Complications, Length of Stay, or Hospital Costs After Minimally Invasive Transforaminal Lumbar Interbody Fusion. Clin Spine Surg. 2020 08; 33(7):E307-E311.
Score: 0.127
-
Iliac Crest Bone Graft for Minimally Invasive Transforaminal Lumbar Interbody Fusion: A Prospective Analysis of Inpatient Pain, Narcotics Consumption, and Costs. Spine (Phila Pa 1976). 2018 09 15; 43(18):1307-1312.
Score: 0.112
-
Preoperative Mental Health is not Predictive of Patient-reported Outcomes Following a Minimally Invasive Lumbar Discectomy. Clin Spine Surg. 2017 Dec; 30(10):E1388-E1391.
Score: 0.106
-
The Utility of Routinely Obtaining Postoperative Laboratory Studies Following a Minimally Invasive Transforaminal Lumbar Interbody Fusion. Clin Spine Surg. 2017 Dec; 30(10):E1405-E1410.
Score: 0.106
-
Multimodal Analgesia Versus Intravenous Patient-Controlled Analgesia for Minimally Invasive Transforaminal Lumbar Interbody Fusion Procedures. Spine (Phila Pa 1976). 2017 Aug 01; 42(15):1145-1150.
Score: 0.103
-
Bone Morphogenetic Proteins in Lumbar Arthrodesis: What Is All the Debate About? Commentary on an article by Daniel C. Beachler, PhD, MHS, et al.: "Bone Morphogenetic Protein Use and Cancer Risk Among Patients Undergoing Lumbar Arthrodesis: A Case-Cohort Study Using the SEER-Medicare Database". J Bone Joint Surg Am. 2016 07 06; 98(13):e57.
Score: 0.096
-
Prospective, randomized, controlled trial of silicate-substituted calcium phosphate versus rhBMP-2 in a minimally invasive transforaminal lumbar interbody fusion. Spine (Phila Pa 1976). 2014 Feb 01; 39(3):185-91.
Score: 0.081
-
Incidence, outcomes, and mortality of reintubation after anterior cervical fusion. Spine (Phila Pa 1976). 2014 Jan 15; 39(2):134-9.
Score: 0.081
-
Incidence, risk factors, and mortality associated with aspiration in cervical spine surgery. Spine (Phila Pa 1976). 2013 Sep 01; 38(19):E1189-95.
Score: 0.079
-
Incidence and risk factors for gastrointestinal hemorrhage after lumbar fusion. Spine (Phila Pa 1976). 2013 Aug 15; 38(18):1584-9.
Score: 0.079
-
Use of recombinant human bone morphogenetic protein-2 as an adjunct in posterolateral lumbar spine fusion: a prospective CT-scan analysis at one and two years. J Spinal Disord Tech. 2006 Aug; 19(6):416-23.
Score: 0.048
-
Congenital lumbar spinal stenosis: a prospective, control-matched, cohort radiographic analysis. Spine J. 2005 Nov-Dec; 5(6):615-22.
Score: 0.046
-
A prospective cohort analysis of adjacent vertebral body bone mineral density in lumbar surgery patients with or without instrumented posterolateral fusion: a 9- to 12-year follow-up. Spine (Phila Pa 1976). 2005 Aug 01; 30(15):1750-5.
Score: 0.045
-
Timing of Complications After Spinal Fusion Surgery. Spine (Phila Pa 1976). 2015 Oct 01; 40(19):1527-35.
Score: 0.023